US5039705A
(en)
*
|
1989-09-15 |
1991-08-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
|
US5208233A
(en)
*
|
1989-09-15 |
1993-05-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
|
US5721365A
(en)
*
|
1989-09-15 |
1998-02-24 |
Us Health |
N-substituted piperazine NONOates
|
US5212204A
(en)
*
|
1989-10-18 |
1993-05-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
Antihypertensive compositions and use thereof
|
WO1994020415A1
(en)
*
|
1992-06-30 |
1994-09-15 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Method of generating nitric oxide gas using nitric oxide complexes
|
US5155137A
(en)
*
|
1990-09-20 |
1992-10-13 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Complexes of nitric oxide with polyamines
|
US5570683A
(en)
*
|
1990-12-05 |
1996-11-05 |
The General Hospital Corporation |
Methods and devices for treating pulmonary vasoconstriction and asthma
|
US5536241A
(en)
*
|
1990-12-05 |
1996-07-16 |
The General Hospital Corporation |
Methods and devices for relaxing smooth muscle contractions
|
DE69127756T2
(de)
*
|
1990-12-05 |
1998-02-05 |
Gen Hospital Corp |
Verwendung von no zur behandlung oder prävention der bronchokonstriktion
|
US5185376A
(en)
*
|
1991-09-24 |
1993-02-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof
|
DE69223157T2
(de)
*
|
1991-09-24 |
1998-06-10 |
Us Health |
Sauerstoff-substituierte derivate von nucleophil-stickstoffoxid-addukten und ihre verwendung als stickstoffoxid-donor-prodrugs
|
US5389675A
(en)
*
|
1992-03-27 |
1995-02-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents
|
WO1993020806A1
(en)
*
|
1992-04-13 |
1993-10-28 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Use of nitric oxide/nucleophile complexes for the treatment of cancer
|
US5814666A
(en)
*
|
1992-04-13 |
1998-09-29 |
The United States As Represented By The Department Of Health And Human Services |
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
|
US5691423A
(en)
*
|
1992-08-24 |
1997-11-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polysaccharide-bound nitric oxide-nucleophile adducts
|
US5650447A
(en)
*
|
1992-08-24 |
1997-07-22 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Nitric oxide-releasing polymers to treat restenosis and related disorders
|
US5632981A
(en)
|
1992-08-24 |
1997-05-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
US6200558B1
(en)
|
1993-09-14 |
2001-03-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
US5405919A
(en)
*
|
1992-08-24 |
1995-04-11 |
The United States Of America As Represented By The Secretary Of Health And Human Services |
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
|
US5525357A
(en)
*
|
1992-08-24 |
1996-06-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
US5910316A
(en)
*
|
1992-08-24 |
1999-06-08 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Use of nitric oxide-releasing agents to treat impotency
|
US5385940A
(en)
*
|
1992-11-05 |
1995-01-31 |
The General Hospital Corporation |
Treatment of stroke with nitric-oxide releasing compounds
|
US5945452A
(en)
*
|
1993-06-11 |
1999-08-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
|
US5891459A
(en)
*
|
1993-06-11 |
1999-04-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
|
US6255277B1
(en)
|
1993-09-17 |
2001-07-03 |
Brigham And Women's Hospital |
Localized use of nitric oxide-adducts to prevent internal tissue damage
|
US6087479A
(en)
*
|
1993-09-17 |
2000-07-11 |
Nitromed, Inc. |
Localized use of nitric oxide-adducts to prevent internal tissue damage
|
EP1393723A3
(de)
*
|
1993-09-17 |
2004-10-20 |
The Brigham And Women's Hospital, Inc. |
Verwendung von Stickstoffoxid-addukten zur Vorbeugung von Thrombosen auf künstlichen und vaskularen Oberflächen
|
US5358703A
(en)
*
|
1993-09-27 |
1994-10-25 |
Mcw Research Foundation, Inc. |
Method for the detection of nitric oxide
|
AU7972294A
(en)
*
|
1993-10-07 |
1995-05-01 |
Entremed, Inc |
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
|
US5840759A
(en)
*
|
1993-10-08 |
1998-11-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
|
EP0722320B1
(de)
*
|
1993-10-08 |
2000-07-19 |
THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services |
Verwendung von stickstoffoxid freisetzenden verbindungen als arzneimittel zur strahlungssensibilisation fur hypoxische zellen
|
US5482925A
(en)
*
|
1994-03-17 |
1996-01-09 |
Comedicus Incorporated |
Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
|
US5519020A
(en)
*
|
1994-10-28 |
1996-05-21 |
The University Of Akron |
Polymeric wound healing accelerators
|
US6063407A
(en)
*
|
1995-02-16 |
2000-05-16 |
The General Hospital Corporation |
Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
|
US5823180A
(en)
*
|
1995-04-03 |
1998-10-20 |
The General Hospital Corporation |
Methods for treating pulmonary vasoconstriction and asthma
|
US5698738A
(en)
*
|
1995-05-15 |
1997-12-16 |
Board Of Regents, The University Of Texas System |
N-nitroso-N-substituted hydroxylamines as nitric oxide donors
|
US5645839A
(en)
*
|
1995-06-07 |
1997-07-08 |
Trustees Of Boston University |
Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
|
US5714511A
(en)
*
|
1995-07-31 |
1998-02-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
|
CN1208053C
(zh)
*
|
1996-04-05 |
2005-06-29 |
综合医院公司 |
气体氧化氮在制备用于治疗血红蛋白病的冶疗气体中的应用
|
EP2292630B1
(de)
|
1996-09-27 |
2015-11-25 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
O2-substituierte 1-(2-carboxylato)pyrrolidin-1-yl Diazen-1-ium-1,2-Diolate
|
US6232336B1
(en)
*
|
1997-07-03 |
2001-05-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
|
WO1999051252A1
(en)
*
|
1998-04-03 |
1999-10-14 |
The Daily Wellness Company |
Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
|
US7371415B1
(en)
|
1998-04-03 |
2008-05-13 |
The Daily Wellness Company |
Method and composition for improving sexual fitness
|
US20050196470A9
(en)
*
|
1998-04-03 |
2005-09-08 |
Wuh Hank C |
Method and composition for enhancing sexual desire
|
US6103275A
(en)
*
|
1998-06-10 |
2000-08-15 |
Nitric Oxide Solutions |
Systems and methods for topical treatment with nitric oxide
|
US20040043068A1
(en)
*
|
1998-09-29 |
2004-03-04 |
Eugene Tedeschi |
Uses for medical devices having a lubricious, nitric oxide-releasing coating
|
CA2254645A1
(en)
*
|
1998-11-23 |
2000-05-23 |
Pulmonox Medical Corporation |
Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
|
US6261594B1
(en)
|
1998-11-25 |
2001-07-17 |
The University Of Akron |
Chitosan-based nitric oxide donor compositions
|
US6605115B1
(en)
*
|
1999-06-05 |
2003-08-12 |
Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for inhibiting cardiovascular cell proliferation
|
US7516742B2
(en)
*
|
1999-11-24 |
2009-04-14 |
Cardinal Health 207, Inc. |
Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
|
US6270779B1
(en)
*
|
2000-05-10 |
2001-08-07 |
United States Of America |
Nitric oxide-releasing metallic medical devices
|
US6989164B2
(en)
|
2000-12-22 |
2006-01-24 |
The Daily Wellness Company |
Method and composition for improving male fertility health
|
US6497885B2
(en)
|
2000-12-22 |
2002-12-24 |
The Daily Wellness Company |
Method and composition for improving fertility health in female and male animals and humans
|
US7122018B2
(en)
*
|
2000-12-26 |
2006-10-17 |
Sensormedics Corporation |
Device and method for treatment of wounds with nitric oxide
|
US6432077B1
(en)
*
|
2000-12-26 |
2002-08-13 |
Sensormedics Corporation |
Device and method for treatment of surface infections with nitric oxide
|
AU2002247127A1
(en)
*
|
2001-02-14 |
2002-08-28 |
Duke University |
Therapy for cerebral vasospasm
|
WO2002083074A2
(en)
*
|
2001-04-13 |
2002-10-24 |
Children's Hospital Medical Center |
Methods for the treatment of hepatic disorders
|
EP2147679B1
(de)
|
2001-07-25 |
2014-06-25 |
Raptor Pharmaceutical, Inc. |
Zusammensetzungen für den Blut-Hirn-Schrankentransport
|
EP1436018A1
(de)
*
|
2001-09-26 |
2004-07-14 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Stickoxid freisetzende beschichtete medizinprodukte und verfahren zu ihrer herstellung
|
US6703046B2
(en)
*
|
2001-10-04 |
2004-03-09 |
Medtronic Ave Inc. |
Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
|
WO2003080730A1
(en)
|
2002-03-20 |
2003-10-02 |
Michigan Biotechnology Institute |
Conductive polymer-based material
|
WO2003080039A1
(en)
*
|
2002-03-21 |
2003-10-02 |
The University Of Utah Research Foundation |
In vivo use of glutathionone s-transferase activated nitric oxide donors
|
US20040038947A1
(en)
*
|
2002-06-14 |
2004-02-26 |
The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services |
Method of treating ischemia/reperfusion injury with nitroxyl donors
|
US6949530B2
(en)
*
|
2002-07-18 |
2005-09-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
|
WO2004012874A1
(en)
|
2002-08-02 |
2004-02-12 |
The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services |
Cross-linked nitric oxide-releasing polyamine coated substrates, compositions comprising same and method of making same
|
US6951902B2
(en)
*
|
2002-08-16 |
2005-10-04 |
Michigan Biotechnology Institute |
Two dimensional polymer that generates nitric oxide
|
US6936639B2
(en)
*
|
2002-08-21 |
2005-08-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Nitroxyl progenitors in the treatment of heart failure
|
US7531133B2
(en)
*
|
2002-09-10 |
2009-05-12 |
Pulmonox Technologies Corporation |
Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
|
US20050009789A1
(en)
*
|
2003-05-13 |
2005-01-13 |
The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Service |
Cyclooxygenase inhibition with nitroxyl
|
US8722103B2
(en)
*
|
2003-07-03 |
2014-05-13 |
University Court Of The University Of St. Andrews |
Zeolites for delivery of nitric oxide
|
EP1718621A4
(de)
*
|
2004-01-30 |
2009-08-19 |
Univ Johns Hopkins |
Nitroxylvorläuferverbindungen anwendungsverfahren
|
CA2555552A1
(en)
*
|
2004-02-09 |
2005-09-09 |
Noxilizer, Inc. |
Nitric oxide-releasing molecules
|
WO2005084301A2
(en)
*
|
2004-03-01 |
2005-09-15 |
Lumen Therapeutics, Llc |
Compositions and methods for treating diseases
|
US8741402B2
(en)
|
2004-04-02 |
2014-06-03 |
Curwood, Inc. |
Webs with synergists that promote or preserve the desirable color of meat
|
US8470417B2
(en)
|
2004-04-02 |
2013-06-25 |
Curwood, Inc. |
Packaging inserts with myoglobin blooming agents, packages and methods for packaging
|
US8545950B2
(en)
|
2004-04-02 |
2013-10-01 |
Curwood, Inc. |
Method for distributing a myoglobin-containing food product
|
US8053047B2
(en)
|
2004-04-02 |
2011-11-08 |
Curwood, Inc. |
Packaging method that causes and maintains the preferred red color of fresh meat
|
US7867531B2
(en)
|
2005-04-04 |
2011-01-11 |
Curwood, Inc. |
Myoglobin blooming agent containing shrink films, packages and methods for packaging
|
US8029893B2
(en)
|
2004-04-02 |
2011-10-04 |
Curwood, Inc. |
Myoglobin blooming agent, films, packages and methods for packaging
|
US8110259B2
(en)
|
2004-04-02 |
2012-02-07 |
Curwood, Inc. |
Packaging articles, films and methods that promote or preserve the desirable color of meat
|
US8518457B2
(en)
*
|
2004-05-11 |
2013-08-27 |
Pulmonox Technologies Corporation |
Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
|
JP2007537267A
(ja)
|
2004-05-11 |
2007-12-20 |
センサーメディックス・コーポレイション |
一酸化窒素ガスの間欠的投与
|
EP1794195B1
(de)
|
2004-09-27 |
2014-12-17 |
Government of the United States of America, Represented by the Secretary, Department of Health and Human Services |
Stickoxidabgebende diazeniumdiolisierte acrylnitrilbasierte polymere und zusammensetzungen, medizinische vorrichtungen und verwendungen damit
|
US20070154570A1
(en)
*
|
2004-09-29 |
2007-07-05 |
Miller Christopher C |
Use of nitric oxide in the treatment and disinfection of biofilms
|
WO2006116718A2
(en)
|
2005-04-28 |
2006-11-02 |
Proteus Biomedical, Inc. |
Pharma-informatics system
|
EP1909779A1
(de)
*
|
2005-06-23 |
2008-04-16 |
Johns Hopkins University |
Thiol-empfindliche positiv-inotrope
|
EP1933845A2
(de)
|
2005-08-25 |
2008-06-25 |
Medtronic Vascular, Inc. |
Stickoxid freisetzende biologisch abbaubare polymere als medizinprodukte und beschichtungen dafür
|
US20070053952A1
(en)
*
|
2005-09-07 |
2007-03-08 |
Medtronic Vascular, Inc. |
Nitric oxide-releasing polymers derived from modified polymers
|
WO2007053292A2
(en)
*
|
2005-10-31 |
2007-05-10 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates
|
US20070116785A1
(en)
*
|
2005-11-18 |
2007-05-24 |
Miller Christopher C |
Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
|
US8241619B2
(en)
*
|
2006-05-15 |
2012-08-14 |
Medtronic Vascular, Inc. |
Hindered amine nitric oxide donating polymers for coating medical devices
|
CN101594878A
(zh)
|
2006-09-18 |
2009-12-02 |
雷普特药品公司 |
通过给予受体相关蛋白(rap)-缀合物对肝病症的治疗
|
US8079998B2
(en)
*
|
2006-10-20 |
2011-12-20 |
Pulmonox Technologies Corporation |
Methods and devices for the delivery of therapeutic gases including nitric oxide
|
US20080193566A1
(en)
*
|
2007-02-09 |
2008-08-14 |
Miller Christopher C |
Use of high dose concentrations of gaseous nitric oxide
|
US7811600B2
(en)
*
|
2007-03-08 |
2010-10-12 |
Medtronic Vascular, Inc. |
Nitric oxide donating medical devices and methods of making same
|
US8273828B2
(en)
|
2007-07-24 |
2012-09-25 |
Medtronic Vascular, Inc. |
Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation
|
US20090222088A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Medtronic Vascular, Inc. |
Secondary Amine Containing Nitric Oxide Releasing Polymer Composition
|
JP5529762B2
(ja)
*
|
2008-03-07 |
2014-06-25 |
ユニバーシティー オブ ユタ リサーチ ファンデーション |
活性化一酸化窒素ドナーならびにその作製および使用方法
|
US20090232868A1
(en)
*
|
2008-03-17 |
2009-09-17 |
Medtronic Vascular, Inc. |
Nitric Oxide Releasing Polymer Composition
|
US20090232863A1
(en)
*
|
2008-03-17 |
2009-09-17 |
Medtronic Vascular, Inc. |
Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers
|
US8158187B2
(en)
*
|
2008-12-19 |
2012-04-17 |
Medtronic Vascular, Inc. |
Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices
|
NZ616673A
(en)
|
2009-02-20 |
2014-08-29 |
To Bbb Holding B V |
Glutathione-based drug delivery system
|
US8709465B2
(en)
*
|
2009-04-13 |
2014-04-29 |
Medtronic Vascular, Inc. |
Diazeniumdiolated phosphorylcholine polymers for nitric oxide release
|
ES2942923T3
(es)
|
2009-05-06 |
2023-06-07 |
Laboratory Skin Care Inc |
Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
|
US20110160200A1
(en)
*
|
2009-11-23 |
2011-06-30 |
Cardioxyl Pharmaceuticals, Inc. |
Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension
|
CA2782110A1
(en)
*
|
2009-12-07 |
2011-06-16 |
Johns Hopkins University |
N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
|
EP2509942A2
(de)
|
2009-12-07 |
2012-10-17 |
Johns Hopkins University |
Bis-acylierte hydroxylaminderivate
|
EP2547660B1
(de)
|
2010-03-19 |
2015-01-07 |
The United States Of America, As Represented By The Secretary, Department of Health and Human Services |
Nitroxyl (hno)-freisetzende verbindungen und ihre verwendung zur behandlung von erkrankungen
|
US20110301299A1
(en)
|
2010-06-08 |
2011-12-08 |
Medtronic Vascular, Inc. |
Medical Devices and Polymers Therefor Having PTFE Surfaces Modified With Nitric Oxide-Releasing Polymers
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
KR102561737B1
(ko)
*
|
2015-02-03 |
2023-07-31 |
유니버시티 코트 오브 더 유니버시티 오브 세인트 앤드류스 |
No 함유 조성물
|
KR102363923B1
(ko)
|
2015-09-09 |
2022-02-21 |
어드밴스드 인헐레이션 테라피즈 (에이아이티) 리미티드 |
세기관지염이 있는 유아를 위한 산화질소 흡입 치료
|
WO2018132371A2
(en)
|
2017-01-10 |
2018-07-19 |
United Therapeutics Corporation |
Methods and compositions for treating pulmonary hypertension
|